In a Neutral regime, ICLR's AIQ Score of 54/100 signals mixed conviction. Wait for component alignment before adding exposure. Watch momentum trend for confirmation or fading.
Quick Stats
ICLR's recent component-level deltas are not available in this snapshot. Use the current AIQ, Sharpe, and volatility profile above as the primary read until the next data refresh.
Snapshot: 2026-07-27T10:17:52.424Z.
| Date | AIQ | Mom | Val | Qual | Resilience |
|---|---|---|---|---|---|
| 2026-07-25 | 54 | 50 | 70 | 43 | 48 |
| 2026-07-18 | 57 | 68 | 70 | 43 | 42 |
| 2026-07-11 | 59 | 76 | 70 | 43 | 40 |
| 2026-07-04 | 61 | 85 | 70 | 43 | 38 |
| 2026-06-27 | 59 | 79 | 70 | 43 | 38 |
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AI Analysis Report
Scenario Analysis
AIQ Scenario Builder
ICLR (ICLR) Stock Analysis
ICLR (ICLR) has an AIQ Score of 54/100 in a Neutral regime as of Jul 25, 2026. The main conflict is that component evidence is mixed in the latest snapshot.
ICLR (ICLR) carries an AIQ Score of 54 out of 100, placing it in a mixed signal regime for this snapshot. A mid-range reading typically means component signals are not fully aligned, so interpretation should focus on what is improving versus what is lagging.
Beta is 1.34, implying roughly 34% higher sensitivity than a broad market baseline.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | ICLR is in a Neutral AIQ regime with score 54/100. |
| Signal Conflict | The primary conflict is that component evidence is mixed in the latest snapshot. |
| Factor Evidence | Factor evidence is not available in this snapshot. |
| Persistence | ICLR has scored AIQ 60+ in 13 of the last 60 daily snapshots. 30-day avg: 58/100. 60-day avg: 57/100. |
| Checklist | Status | Evidence |
|---|---|---|
| Factor strength | Wait | No factor has enough evidence to pass this check. |
| Timing | Wait | Momentum is —. |
| Regime fit | Wait | ICLR is in a Neutral regime at 54/100. |
| Risk control | Wait | Risk factor is — with beta of 1.34 indicates above-market sensitivity. |
| Conflict | Pass | Current conflict: component evidence is mixed in the latest snapshot. |
ICLR's recent component-level deltas are not available in this snapshot. Use the current AIQ, Sharpe, and volatility profile above as the primary read until the next data refresh.
Signal snapshot as of 2026-07-27T10:17:52.424Z.
| Metric | Current |
|---|---|
| AIQ Score | 54/100 |
| Price | $165.76 |
| Beta | 1.34 |
ICLR vs Gene Editing / Genomics / Biotech Peers
Portfolio Implication
Related Links
ICLR Stock FAQ
What does the ICLR AIQ Score mean?
AIQ Score summarizes multiple factors for ICLR, including momentum, value, quality, and risk. Higher scores generally indicate stronger combined signals, but you should still validate with your own risk tolerance.
How often is ICLR data updated?
ICLR quote and scoring components refresh on the platform cadence. Always confirm timestamp freshness on-page before making time-sensitive decisions.
Should I compare ICLR with an index before investing?
Yes. Comparing ICLR versus benchmarks like SPY or QQQ helps you separate stock-specific strength from broader market moves.
Where can I review deeper ICLR fundamentals, technicals, and risk?
Use the Fundamentals, Technicals, and Risk tabs from this page to inspect driver-level metrics behind the headline score.
How the AIQ Score Is Built
Methodology, factor weights, and how to interpret score history
Loading ICLR...